Article
Efficacy of Prophylactic Traditional Chinese Medicine on Skin Toxicity of Afatinib in EGFR Mutation-Positive Advanced Lung Adenocarcinoma: A Single-Center, Prospective, Double-Blinded, Randomized-Controlled Pilot Trial.
Integrative cancer therapies - 1 Jan 2000
Li Chia-Ling, Hsia Te-Chun, Yang Su-Tso, Chao Kun-San Clifford, Tu Chih-Yen, Chen Hung-Jen, Li Chia-Hsiang
Abstract excerpt
OBJECTIVES: To evaluate the efficacy of prophylactic traditional Chinese medicine (TCM) on skin toxicities in patients with advanced lung adenocarcinoma treated with first-line epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) in a randomized-controlled trial (RCT). MATERIALS AND METHODS: This pilot study was a prospective, single-center, double-blinded RCT. The study enrolled patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.